SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan

ORION was a prospective, observational study evaluating the safety and effectiveness of the second-generation basal insulin analog Gla-300 in people with type 2 diabetes (T2DM) who fast during Ramadan. Adults with T2DM who intended to fast for ≥15 days during Ramadan, had taken Gla-300 for ≥8 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Mohamed, Buyukbese, Mehmet Akif, Malek, Rachid, Pilorget, Valérie, Naqvi, Mubarak, Berthou, Baptiste, Shaltout, Inass, Sahay, Rakesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208348/
http://dx.doi.org/10.1210/jendso/bvaa046.2134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208348/
http://dx.doi.org/10.1210/jendso/bvaa046.2134

Ejemplares similares